BREAKING NEWS
People can talk anything they want to, I know my game better: Virat Kohli on his strike rate
Vijayapura: Tragedy at Lachyana Maharathotsav – 2 dead, one injured after being crushed by chariot
Diljit Dosanjh makes history, sells out ‘largest ever Punjabi show outside India’
IPL 2024: Jacks, Kohli power RCB to easy win over GT
Pakistan’s Foreign Minister Ishaq Dar appointed as deputy prime minister
Row erupts over Thiruvananthapuram mayor blocking bus in traffic dispute
Chikkamagaluru: At least 30 injured after tourist mini bus overturns near Datta Peetha
IPL 2024: Gujarat Titans post 200 for 3 against RCB
Water supply disruption: Several areas in Mangalore to face cut-off from April 30 to May 1
Siddaramaiah holds dharna protesting Centre’s ‘injustice’ in release of drought relief to Karnataka
Mangaluru: 2 trucks collide at Baikampady; driver hospitalised
Archery WC: Indian men’s team upset Olympic champions Korea to bag historic gold after 14 years
Sanju Samson says mistakes can happen in T20 cricket, but Rajasthan Royals must stick with processes
With impact player, it is getting difficult each and every day: Pant
McGurk, Stubbs rock as DC beat MI by 10 runs
Zydus Cadila gets USFDA nod for muscle relaxant injection
PTI, Sep 2, 2020, 3:53 PM IST
Drug firm Zydus Cadila has received final approval from the US health regulator to market Cisatracurium Besylate Injection, a muscle relaxant given before general anesthesia.
Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Cisatracurium Besylate Injection USP in the strength of 20 mg (base)/10 mL (2 mg/mL) multiple-dose vial, Cadila Healthcare said in a regulatory filing on Wednesday, September 2.
The drug will be manufactured at Liva plant of Cadila Healthcare Ltd. Zydus Cadila is a part of the Cadila Healthcare group.
The group now has 297 approvals and has so far filed over 390 abbreviated new drug applications (ANDAs) since the commencement of the filing process in FY 2003-04.
Shares of Cadila Healthcare, the listed entity of the group, were trading at Rs 377.60 apiece on BSE, 0.15 percent lower against their previous close.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Elon Musk in Beijing amid efforts to promote Tesla’s autonomous driving tech
Corporate earnings, US Fed interest rate decision to drive markets in holiday-shortened week: Analysts
Pune court asks police to probe bribery allegations against IT major Cognizant
Patanjali Foods to evaluate proposal to buy Patanjali Ayurved’s non-food business
Nifty, Sensex rally for 6th day running on firm Asian peers; Tech Mahindra jumps over 12%
MUST WATCH
Latest Additions
Some countries, institutions want weak govt to make easy profits: PM Modi
People can talk anything they want to, I know my game better: Virat Kohli on his strike rate
Sexual harassment, stalking case registered against ex-minister H D Revanna and his son Prajwal
Reservation row: Congress campaign ‘biggest lie’ of the decade, says Kishan Reddy
BJP trying religious polarisation in Nagaon: Congress candidate Pradyut Bordoloi